Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea: a Randomized Controlled Trial

NCT06317064 is registered in ClinicalTrials.gov with Lahore Medical Research Center, LLP as lead sponsor.

NCT NCT06317064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06317064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea: a Randomized Controlled Trial
Lead sponsor
Lahore Medical Research Center, LLP
Phase
Phase 3
Overall status
Completed
Start date
March 15, 2024
Completion date
December 15, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary dysmenorrhea